Friday, 16 October 2026European Markets

TF1 And NRJ GROUP Have A High Dividend Yield And Return On Equity In The Communication Services Sector.

Loading stream...

(vianews) - tf1 (tfi.pa) is among this list of stock assets with the highest dividend rate and return on equity on the communication services sector.

financial asset price forward dividend yield return on equity
tf1 (tfi.pa) €8.47 6.43% 10.07%
nrj group (nrg.pa) €7.86 4.47% 6.55%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. tf1 (tfi.pa)

6.43% forward dividend yield and 10.07% return on equity

tf1 sa engages in the broadcasting, studios and entertainment, and digital businesses in france and internationally. the company offers dtt channels, including tmc, tfx, lci, and tf1 séries films; theme channels, such as tv breizh, ushuaïa tv, serie club, and histoire tv; e-tf1; tf1 production; e-commerce activities; music/events; tf1 business solutions; tf1 films production; websites; and advertising services, as well as tf1, which covers sports, french drama, news, entertainment, and movies. it also provides streaming platforms, such as mytf1, tfou max, and salto; and operates studios, including newen studios. tf1 sa was incorporated in 1982 and is headquartered in boulogne-billancourt, france.

earnings per share

as for profitability, tf1 has a trailing twelve months eps of €0.91.

pe ratio

tf1 has a trailing twelve months price to earnings ratio of 9.31. meaning, the purchaser of the share is investing €9.31 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.07%.

more news about tf1.

2. nrj group (nrg.pa)

4.47% forward dividend yield and 6.55% return on equity

nrj group sa, a private media company, operates as a publisher, producer, and broadcaster in france and internationally. it operates 4 radio stations under the nrj, cherie fm, nostalgie, and rire & chansons brands; approximately 230 digital radios; 6 websites; and 7 mobile applications, as well as a replay tv. the company also operates two national channels, which include nrj 12 and cherie 25; and nrj hits, a music channel for cable satellite. in addition, it engages in advertising activities; marketing activities; operates musical shows under the nrj music label; and audio and audio visual, trademark licensing, and real estate activities. nrj group sa was founded in 1981 and is based in paris, france.

earnings per share

as for profitability, nrj group has a trailing twelve months eps of €0.48.

pe ratio

nrj group has a trailing twelve months price to earnings ratio of 16.38. meaning, the purchaser of the share is investing €16.38 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.55%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, nrj group's stock is considered to be overbought (>=80).

volume

today's last reported volume for nrj group is 7037 which is 62.4% below its average volume of 18716.

volatility

nrj group's last week, last month's, and last quarter's current intraday variation average was 0.26%, 0.20%, and 1.13%.

nrj group's highest amplitude of average volatility was 2.02% (last week), 1.33% (last month), and 1.13% (last quarter).

more news about nrj group.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com